Infibeam Avenues, an Ahmedabad headquartered company recently said it would demerge its SME E-commerce and marketplace businesses to Suvidh...

Swiggy is in talks to close a $700-800 million funding round, even as Zomato IPO plans take shape. Contours of India’s Cryptocurrency Bill ...

The central bank is looking to set up a new payment system in the retail space that would operate in the retail space. The government is ke...

"We believe that this optimism can sustain in the near term with a shift towards mid and small caps, led by lag effect," Vinod Nair, Head o...

In a filing to BSE, the company said that the composite scheme of arrangement will assist Infibeam Avenues to unlock value for its sharehol...

Dr Reddy's Laboratories on Saturday said it has inked a pact with Glenmark Pharmaceuticals to acquire its select anti-allergy brands.

The company had first announced its demerger plans few months ago and now has got an approval from NCLT.

Last year, the Board - on the recommendation of the Audit Committee - had considered and approved the Composite Scheme of Arrangement and r...

Here is a lowdown on what happened in Tuesday’s session.

95% of BSE500 stocks from across sectors have delivered a positive returns since March 24.

The company had posted a net profit of Rs 25.4 crore in the year-ago period.

Through the demerger, Infibeam will continue to focus on digital payments and e-commerce enterprise platform solutions.

On Thursday, Infibeam Avenues’s board decided to demerge its SME ecommerce services and move it into Suvidhaa.

The Indian market is expected to open flat. Here is a list of top fifteen stocks that are likely to be in focus today.